Prolymphocytic Leukemia

• CLINICAL_TRIALS research · 2026-03-17
  Clinical Trial Update: A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation [Phase 2]

  This Phase 2 clinical trial protocol investigates a post-transplant cyclophosphamide–based graft-versus-host disease prophylaxis approach in…

• CLINICAL_TRIALS research · 2025-11-26
  Clinical Trial Update: Observatory of Prolymphocytic Leukemia T

  This is a clinical trial registry entry for an ongoing study on prolymphocytic leukemia of T-cell origin, with recruitment currently ongoing…

• CLINICAL_TRIALS research · 2025-11-06
  Clinical Trial Update: Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia [Phase 2]

  A Phase 2 trial is evaluating ibrutinib with or without rituximab in patients with relapsed chronic lymphocytic leukemia and related lymphop…

• CLINICAL_TRIALS research · 2016-01-28
  Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 [NA]

  Clinical trial update describing CART19 therapy for relapsed and/or chemotherapy-refractory B-cell malignancies with an unknown status of th…

• CLINICAL_TRIALS research · 2015-09-29
  Clinical Trial Update: Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy [Phase 1, Phase 2]

  Clinical trial update describing a Phase 1/Phase 2 study of a genetically engineered lymphocyte therapy for chemotherapy-resistant or refrac…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2007-04-17
  Clinical Trial Update: Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease [Phase 1]

  Phase 1 safety study evaluating CAT-8015 immunotoxin in patients with chronic lymphocytic leukemia, prolymphocytic leukemia, or small lympho…